MJ, R., CJ, P., WD, F., & DA, G. (2022). Dose Optimization of Pembrolizumab: Less May Be More. Clinical pharmacology and therapeutics, 111(5), 993. https://doi.org/10.1002/cpt.2490
Chicago Style (17th ed.) CitationMJ, Ratain, Peer CJ, Figg WD, and Goldstein DA. "Dose Optimization of Pembrolizumab: Less May Be More." Clinical Pharmacology and Therapeutics 111, no. 5 (2022): 993. https://doi.org/10.1002/cpt.2490.
MLA (9th ed.) CitationMJ, Ratain, et al. "Dose Optimization of Pembrolizumab: Less May Be More." Clinical Pharmacology and Therapeutics, vol. 111, no. 5, 2022, p. 993, https://doi.org/10.1002/cpt.2490.
Warning: These citations may not always be 100% accurate.